Concepedia

K. Wallenfeldt

KW

Statistics

Publications

5

Citations

468

H-Index

5

Active since

2001

Affiliations

Sahlgrenska University Hospital(Current)

AstraZeneca (Sweden)

K. Wallenfeldt is an author at Sahlgrenska University Hospital specializing in oxidative stress, vascular biology, and atherosclerosis.

Top concepts

Publications per year

2001–2006

5

Publications

5

Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men

K. Wallenfeldt, Lena Bokemark, John Wikstrand et al. · Stroke · 2004 · 127 citations · Full text

Oxidized low‐density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men

K. Wallenfeldt, Björn Fagerberg, John Wikstrand et al. · Journal of Internal Medicine · 2004 · 117 citations

, , +21

Carotid and femoral atherosclerosis, cardiovascular risk factors and C‐reactive protein in relation to smokeless tobacco use or smoking in 58‐year‐old men

K. Wallenfeldt, J. Hulthe, L. Bokemark et al. · Journal of Internal Medicine · 2001 · 104 citations

Circulating Estradiol Is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men

Åsa Tivesten, Johannes Hulthe, K. Wallenfeldt et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 68 citations · Full text

The metabolic syndrome in middle‐aged men according to different definitions and related changes in carotid artery intima‐media thickness (IMT) during 3 years of follow‐up

K. Wallenfeldt, J. Hulthe, Björn Fagerberg · Journal of Internal Medicine · 2005 · 52 citations · Full text

1–5 of 5